CSF drug levels for children with acute lymphoblastic leukemia treated by 5 g/m2 methotrexate. A study from the EORTC childrens' leukemia cooperative group

European Journal of Cancer and Clinical Oncology

Volumn 26, Issue 4, 1990, Pages 492-495

  Milano, G ^a   Thyss, A ^a   Serre Debeauvais, F ^b   Laureys, G ^c   Benoit, Y ^c   Deville, A ^a   Dutour, C ^d   Robert, A ^d   Otten, J ^e   Behar, C ^f   Frappaz, D ^g  

^a CENTRE ANTOINE LACASSAGNE   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c Klinick Voor Kinderziekten ^*  (Belgium)

^d CHU PURPAN   (France)

^e VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^f AMERICAN HOSPITAL OF PARIS   (France)

^g HÔPITAL MICHALLON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; METHOTREXATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; AGE; ARTICLE; CHILD; CHILDHOOD LEUKEMIA; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADOLESCENT; AGE FACTORS; ANALYSIS OF VARIANCE; CHILD; CHILD, PRESCHOOL; EUROPE; FEMALE; HUMAN; INFANT; INFUSIONS, INTRAVENOUS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; METHOTREXATE; MULTICENTER STUDIES;

EID: 0025293847     PISSN: 02775379     EISSN: None     Source Type: Journal    
DOI: 10.1016/0277-5379(90)90023-M     Document Type: Article

References (21)

1. Remission induction of meningeal leukemia with high-dose intravenous methotrexate
2. High dose methotrexate: a critical reappraisal
3. Central nervous system involvement in non-Hodgkin's lymphoma: an analysis of 105 cases
4. Comparison of intermediate-dose methotrexate with cranial irradiation for the post-induction treatment of acute lymphocytic leukemia in children
5. The use of intermediate dose methotrexate in increased risk childhood acute lymphoblastic leukemia
6. Methotrexate cerebrospinal fluid and serum concentration after intermediate dose methotrexate infusion
7. Pharmacokinetics of methotrexate following intravenous and intraventricular administration in acute lymphocytic leukemia and non-Hodgkin's lymphoma
8. Active transport of methotrexate from cerebrospinal fluid in humans
9. Treatment of leukemia with large doses of methotrexate and folinic acid: clinical biochemical correlates
10. Methotrexate: distribution in cerebrospinal fluid after intravenous ventricular and lumbar injections
11. High dose methotrexate with citrovorum factor rescue for the treatment of central nervous system tumors in children
12. Effect of dose and repeat intravenous 24 hr infusions of methotrexate on cerebrospinal fluid availability in children with hematological malignancies
13. Leukoencephalopathy following high-dose i.v. methotrexate chemotherapy with leucovorin rescue
14. Treatment of acute lymphoblastic leukemia in children with the BFM protocol; a cooperative study and analysis of prognostic factors
15. Abschatzung der Tumorzellmasse bei der akuten lymphoblastichen Leukamie im Kindesalter: prognostiche Bedeutung und praktische Anwendung
16. Enzymatic assay MTX, centrifugal analyser
17. Methotrexate
18. 2 in children with acute lymphoblastic leukemia
19. Prolonged methotrexate infusions in children with acute leukemia in relapse and in remission and with medulloblastoma
20. Change in transfer rate of methotrexate from spinal fluid to plasma during intrathecal therapy in children and adults
21. Evidence for CSF accumulation of 5-methyltetrahydrofolate during repeated courses of methotrexate plus folinic acid rescue